These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11154106)

  • 1. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM; Gomes L; Marquart JA; Vink T; Meijers JC; de Groot PG; Sixma JJ; Huizinga EG
    Thromb Haemost; 2000 Dec; 84(6):1005-11. PubMed ID: 11154106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS; Loisel I; Lavergne JM; Juhan-Vague I; Obert B; Cherel G; Meyer D; Girma JP
    Thromb Haemost; 2001 Sep; 86(3):848-54. PubMed ID: 11583318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
    Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
    Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1999 Jun; 81(6):976-83. PubMed ID: 10404778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment.
    Nishida N; Sumikawa H; Sakakura M; Shimba N; Takahashi H; Terasawa H; Suzuki E; Shimada I
    Nat Struct Biol; 2003 Jan; 10(1):53-8. PubMed ID: 12447349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay.
    Saenko E; Kannicht C; Loster K; Sarafanov A; Khrenov A; Kouiavskaia D; Shima M; Ananyeva N; Schwinn H; Gruber G; Josic D
    Anal Biochem; 2002 Mar; 302(2):252-62. PubMed ID: 11878805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF.
    Vanhoorelbeke K; van der Plas RM; Vandecasteele G; Vauterin S; Huizinga EG; Sixma JJ; Deckmyn H
    Thromb Haemost; 2000 Oct; 84(4):621-5. PubMed ID: 11057860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the collagen-binding site in the von Willebrand factor-A3 domain.
    Romijn RA; Westein E; Bouma B; Schiphorst ME; Sixma JJ; Lenting PJ; Huizinga EG
    J Biol Chem; 2003 Apr; 278(17):15035-9. PubMed ID: 12582178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of von Willebrand factor (vWf) with collagen: investigation of vWf-binding sites in the collagen molecule.
    Fitzsimmons CM; Cockburn CG; Hornsey V; Prowse CV; Barnes MJ
    Thromb Haemost; 1988 Apr; 59(2):186-92. PubMed ID: 3260414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational stability and domain unfolding of the Von Willebrand factor A domains.
    Auton M; Cruz MA; Moake J
    J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
    Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
    Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.
    Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV
    Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
    Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen.
    Komorowic E; McBane RD; Charlesworth J; Fass DN
    Thromb Haemost; 2002 Apr; 87(4):763-70. PubMed ID: 12013023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain.
    Hellings M; Engelborghs Y; Deckmyn H; Vanhoorelbeke K; Schiphorst ME; Akkerman JW; De Maeyer M
    Proteins; 2004 Nov; 57(3):596-601. PubMed ID: 15382239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.